Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

  • August 21, 2018
Table of Contents

Newly Found Enzymes Can Help Turn Type A and B Blood into Universal Type O

A team of researchers headed by University of British Columbia scientist Stephen Withers reports on enzymes — from the human gut — that remove A or B antigens from red blood cells 30 times more efficiently than previously reported enzymes. To assess potential enzyme candidates more quickly, Dr. Withers and colleagues used a technique called metagenomics. The team considered sampling DNA from mosquitoes and leeches, the types of organisms that degrade blood, but ultimately found successful candidate enzymes in the human gut microbiome.

Glycosylated proteins called mucins line the gut wall, providing sugars that serve as attachment points for gut bacteria while also feeding them as they assist in digestion. Some of the mucin sugars are similar in structure to the antigens on A- and B-type blood. The scientists homed in on the enzymes the bacteria use to pluck the sugars off mucin and found a new family of enzymes that are 30 times more effective at removing red blood cell antigens than previously reported candidates.

The researchers presented their results today at the 256th National Meeting & Exposition of the American Chemical Society in Boston, Massachusetts.

Source: sci-news.com

Share :
comments powered by Disqus

Related Posts

Cancer cells engineered with CRISPR slay their own kin

Cancer cells engineered with CRISPR slay their own kin

Using gene editing, scientists have hoodwinked tumor cells into turning against their own kind. Cancer cells circulating in the bloodstream have something of a homing instinct, able to find and return to the tumor where they originated. To capitalize on that ability, researchers engineered these roving tumor cells to secrete a protein that triggers a death switch in resident tumor cells they encounter.

Read More
The inconvenient truth about cancer and mobile phones

The inconvenient truth about cancer and mobile phones

On 28 March this year, the scientific peer review of a landmark United States government study concluded that there is “clear evidence” that radiation from mobile phones causes cancer, specifically, a heart tissue cancer in rats that is too rare to be explained as random occurrence. Eleven independent scientists spent three days at Research Triangle Park, North Carolina, discussing the study, which was done by the National Toxicology Program of the US Department of Health and Human Services and ranks among the largest conducted of the health effects of mobile phone radiation. NTP scientists had exposed thousands of rats and mice (whose biological similarities to humans make them useful indicators of human health risks) to doses of radiation equivalent to an average mobile user’s lifetime exposure.

Read More
New anti-cancer drugs put cancers to sleep—permanently

New anti-cancer drugs put cancers to sleep—permanently

In a world first, Melbourne scientists have discovered a new type of anti-cancer drug that can put cancer cells into a permanent sleep, without the harmful side-effects caused by conventional cancer therapies. Published today in the journal Nature, the research reveals the first class of anti-cancer drugs that work by putting the cancer cell to sleep – arresting tumour growth and spread without damaging the cells’ DNA. The new class of drugs could provide an exciting alternative for people with cancer, and has already shown great promise in halting cancer progression in models of blood and liver cancers, as well as in delaying cancer relapse.

Read More